The State Of The Art Of Bispecific Antibodies For Treating Human Malignancies
EMBO MOLECULAR MEDICINE(2021)
摘要
Bispecific antibodies (bsAb) that target two independent epitopes or antigens have been extensively explored in translational and clinical studies since they were first developed in the 1960s. Many bsAbs are being tested in clinical trials for treating a variety of diseases, mostly cancer. Here, we provide an overview of various types of bsAbs in clinical studies and discuss their targets, safety profiles, and efficacy. We also highlight the current challenges, potential solutions, and future directions of bsAb development for cancer treatment.
更多查看译文
关键词
bispecific antibodies (bsAb), malignancies, single-chain variable fragment (scFvs), tumor associate antigen, tumor-specific antigen
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要